Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

US-friendly broker Finpari

 

Enter Stock Symbol:  

Regulus Therapeutics (RGLS)

1.70 +0.30 (+21.43%)

3/27/2017  4:00pm

Open:

1.50

Pre. Close:

1.40

High:

1.75

Low:

1.45

Volume:

3,938,589

Market Cap:

89.98M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

1.8 - 1.81

1.81 - 1.82

Low:

1.38 - 1.4

1.4 - 1.42

Close:

1.65 - 1.69

1.69 - 1.75

Technical analysis  (as of: 2017-03-27 4:37:47 PM)

Overall:

      

Stoxline posted a BUY today, downgraded from strong buy. But this stock still is very strong for long buyers. If you bought, continue to hold stock until SELL signal. You are relatively safe as long as the SELL warning is not issued.

Target:

Six months: 2.04     One year: 2.39

Support:

Support1: 1.25    Support2: 0.94

Resistance:

Resistance1: 1.75    Resistance2: 2.04

Pivot:

1.30

Moving Averages:

MA(5): 1.36     MA(20): 1.25

MA(100): 1.99     MA(250): 3.48

MACD:

MACD(12,26): 0.01     Signal(12,26,9): -0.05

%K %D:

%K(14,3): 71.43     %D(3): 60.14

RSI:

RSI(14): 69.54

52-Week:

High: 8.90  Low: 0.94  Change(%): -74.0

Average Vol(K):

3-Month: 1032  10-Days 1446

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
RGLS has closed above the upper band by 28.4%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 29.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Mon, 27 Mar 2017 21:56:15 GMT
SHAREHOLDER ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit ...

Mon, 27 Mar 2017 17:37:30 GMT
Regulus Therapeutics Inc. (RGLS): What's the Story?

Mon, 27 Mar 2017 13:44:53 GMT
Increased Volume Spurs Stock Prices of Benitec Biopharma, Regulus Therapeutics

Mon, 27 Mar 2017 12:33:45 GMT
Between The Numbers: Regulus Therapeutics Inc. (RGLS), CBL & Associates ...

Wed, 15 Mar 2017 21:32:39 GMT
Regulus Therapeutics Inc. (RGLS) Plunges 7.14% on March 15

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology Medical Research

Shares Out. (M)

52.93

Shares Float (M)

36.69

% Held by Insiders

42.92

% Held by Institutions

65.50

Shares Short (K)

2870

Shares Short Prior Month (K)

3580

Stock Financials

EPS

-1.550

EPS Est. Current Year

EPS Est. Next Year

EPS Est. Next Quarter

Forward EPS

Book Value (p.s.)

1.060

PEG Ratio

-0.02

Profit Margin

Operating Margin

-6825.96

Return on Assets (ttm)

-42.1

Return on Equity (ttm)

-90.8

Qtrly Rev. Growth

-99.8

Gross Profit (p.s.)

0.022

Sales Per Share

0.022

EBITDA (p.s.)

-1.497

Qtrly Earnings Growth

Operating Cash Flow (M)

-56.88

Levered Free Cash Flow (M)

-27.49

FoxReading.com

Valuation

P/E

-1.10

P/E Growth Ratio

0.21

P/BV

1.60

P/S

75.61

P/CF

-1.58

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.